{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:52:41Z","timestamp":1790214761629,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":3964,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>. To assess red blood cell deformability (RCD) in patients with rheumatoid arthritis (RA) without extraarticular manifestations and in RA with vasculitic complications (RV), and to assess whether in vitro dipyridamole improves RCD.<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>. An improved filtration technique was used to measure RCD in 15 patients with RA, 18 patients with RV, and 20 age\u2010 and sex\u2010matched normal control subjects. Washed erythrocytes suspended in buffer, at 5% hematocrit, were filtered through 4.7 \u03bc Nuclepore Hemafil PC membranes. The initial steadystate relative filtration pressure (iRFP) was used as an index to assess RCD. A lower iRFP value reflects increased deformability, a higher value reflects a decrease. For each sample, 2 cell suspensions were prepared, one blank (control) and one containing 5 <jats:italic>\u03bcM<\/jats:italic> dipyridamole.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. The mean iRFP values of cells obtained from patients with RV were significantly higher than those of cells obtained from normal controls. There were no appreciable differences in iRFP between RA patients and normal controls. When the erythrocytes were pretreated in vitro with 5 <jats:italic>\u03bcM<\/jats:italic> dipyridamole before filtration, their deformability improved markedly (iRFP values were reduced) in all study subjects, compared with untreated cells.<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>. RCD is reduced in patients with RV, and treatment with dipyridamole may be beneficial if reduced RCD contributes to impaired microvascular perfusion.<\/jats:p>","DOI":"10.1002\/art.1780380214","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:40:10Z","timestamp":1171503610000},"page":"248-253","source":"Crossref","is-referenced-by-count":7,"title":["Reduced red blood cell deformability in patients with rheumatoid vasculitis improvement after in vitro treatment with dipyridamole"],"prefix":"10.1002","volume":"38","author":[{"given":"C. S.","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Saniabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J. F.","family":"Belch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198611000-00002"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00270462"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.9.643"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6287.350"},{"key":"e_1_2_1_6_2","first-page":"263","article-title":"A study of the effect of dipyridamole on erythrocyte deformability using an improved filtration technique","volume":"10","author":"Saniabadi AR","year":"1990","journal-title":"Clin Hemorhoel"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265931"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.29.9.855"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(87)80018-5"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582631"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(87)80023-9"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb02077.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/003693308703200106","article-title":"Abnormal biochemical and cellular parameters in the blood of patients with Raynaud's phenomenon","volume":"32","author":"Belch JJF","year":"1987","journal-title":"Scott Med J"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0650515"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.5.424"},{"key":"e_1_2_1_17_2","first-page":"591","article-title":"Hemorheological abnormalities in rheumatoid arthritis","volume":"7","author":"Ernst E","year":"1987","journal-title":"Clin Hemorheol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/25.3.177"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb05888.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.2.124"},{"key":"e_1_2_1_21_2","volume-title":"The white blood cell: a new cardiovascular risk factor? Coronary Risk Factors Revisited","author":"Belch JJF","year":"1989"},{"key":"e_1_2_1_22_2","first-page":"115","article-title":"The acute\u2010phase reaction and haematological stress syndrome in vascular disease","volume":"3","author":"Stuart J","year":"1984","journal-title":"Int J Microcirc Clin Exp"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01966658"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V71.5.1427.1427","article-title":"The relationship between in vivo haemoglobin skeletal protein complex and red cell membrane rigidity","volume":"71","author":"Fortier NM","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_25_2","first-page":"217","article-title":"Wirkung von Dipyridamole und von Prednisolon auf Lysophospholipase von Erythrocyten","volume":"344","author":"Ferber E","year":"1966","journal-title":"Biochem Z"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(87)90061-X"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331978703801103"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91269-2"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90303-6"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780380214","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780380214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T09:53:07Z","timestamp":1696153987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780380214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1002\/art.1780380214"],"URL":"https:\/\/doi.org\/10.1002\/art.1780380214","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}